Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials (Q39830867)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials |
scientific article |
Statements
1 reference
Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials (English)
1 reference
Philip J Rosenfeld
1 reference
Howard Shapiro
1 reference
Lisa Tuomi
1 reference
Mary Webster
1 reference
Julee Elledge
1 reference
Barbara Blodi
1 reference
MARINA and ANCHOR Study Groups
1 reference
1 March 2011
1 reference
1 reference
Identifiers
1 reference